IRMD logo

IRADIMED CORPORATION Stock Price

NasdaqGM:IRMD Community·US$1.2b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 14 Fair Values set on narratives written by author

IRMD Share Price Performance

US$91.69
31.29 (51.80%)
US$118.00
Fair Value
US$91.69
31.29 (51.80%)
22.3% undervalued intrinsic discount
US$118.00
Fair Value
Price US$91.69
AnalystConsensusTarget US$118.00

IRMD Community Narratives

·
Fair Value US$118 19.8% undervalued intrinsic discount

IRMD: Index Addition and Strong Margins Will Support Measured Upside

0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
US$118
19.8% undervalued intrinsic discount
Revenue
9.66% p.a.
Profit Margin
28.09%
Future PE
54.96x
Price in 2029
US$135.37

Trending Discussion

Updated Narratives

IRMD logo

IRMD: 2026 Guidance And Bullish Initiation Will Drive Further Re Rating

Fair Value: US$118 19.8% undervalued intrinsic discount
5 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Flawless balance sheet with solid track record.

1 Risk
2 Rewards

IRADIMED CORPORATION Key Details

US$86.3m

Revenue

US$20.0m

Cost of Revenue

US$66.3m

Gross Profit

US$42.7m

Other Expenses

US$23.6m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
1.85
76.84%
27.36%
0%
View Full Analysis

About IRMD

Founded
1992
Employees
166
CEO
Roger Susi
WebsiteView website
www.iradimed.com

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. It also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. The company serves hospitals, acute care facilities, and outpatient imaging centers. It sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors in the United States and internationally. The company was incorporated in 1992 and is headquartered in Orlando, Florida.

Recent IRMD News & Updates

Analysis Article Jun 22

IRADIMED (IRMD) Stock Could Be 21.9% Undervalued on Its MRI Pump Upgrade Narrative

With no single headline event driving attention to IRADIMED (IRMD) today, investors are instead looking at the stock’s recent performance record and financial profile to reassess how it fits into a healthcare portfolio. See our latest analysis for IRADIMED. IRADIMED’s share price has been choppy in recent months, with the stock down around 7% over 90 days and 3% year to date, yet its 1 year total shareholder return of about 61% and 5 year total shareholder return above 250% still point to...
Narrative Update Jun 18

IRMD: 2026 Guidance And Bullish Initiation Will Drive Further Re Rating

Analysts have maintained their $118 price target on IRADIMED, citing recent bullish initiation and supporting research that highlight the company's long-term earnings potential, along with a still-elevated forward P/E profile. What’s in the News for IRADIMED IRADIMED issued earnings guidance for the second quarter of 2026, with expected revenue in a range of US$20.0 million to US$21.0 million and GAAP diluted EPS between US$0.40 and US$0.44.

Recent updates

No updates